Crenigacestat, a Selective NOTCH1 Inhibitor, Reduces Intrahepatic Cholangiocarcinoma Progression by Blocking VEGFA/DLL4/MMP13 Axis

Cell Death and Differentiation - United Kingdom
doi 10.1038/s41418-020-0505-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Intrahepatic Cholangiocarcinoma

2020English

Intrahepatic Cholangiocarcinoma

2018English

Intrahepatic Sarcomatoid Cholangiocarcinoma

Journal of Oncology
Oncology
2010English

A Case of Intrahepatic Cholangiocarcinoma With Intrahepatic Stones.

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
1992English

Intrahepatic Cholangiocarcinoma: MR Appearance.

American Journal of Roentgenology
MedicineNuclear MedicineRadiologyImaging
1992English

circRNA‑CER Mediates Malignant Progression of Breast Cancer Through Targeting the miR‑136/MMP13 Axis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Molecular Diagnosis of Intrahepatic Cholangiocarcinoma

Journal of Hepato-Biliary-Pancreatic Sciences
SurgeryHepatology
2014English

KCa3.1 as an Effective Target for Inhibition of Growth and Progression of Intrahepatic Cholangiocarcinoma

Journal of Cancer
Oncology
2017English

Intrahepatic Cholangiocarcinoma: Expert Consensus Statement

HPB
HepatologyGastroenterology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy